Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): A single-institution study of 224 Japanese AML patients

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 471-476

  Monma, Fumihiko ^a   Nishii, Kazuhiro ^a   Shiga, Junko ^a   Sugahara, Haruka ^a   Lorenzo V, Felipe ^a   Watanabe, Yasuyuki ^b   Kawakami, Keiki ^b   Hosokai, Noboru ^c   Yamamori, Shunji ^c   Katayama, Naoyuki ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUZUKA GENERAL HOSPITAL   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Acute myeloid leukemia; CBFB MYH11; Core binding factor leukemia; Eosinophilia; FISH; inv(16); RT PCR

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CBFB GENE; CHROMOSOME 13P; CHROMOSOME 16; CHROMOSOME 22P; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EOSINOPHILIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; JAPANESE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYH11 GENE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ADULT; CHROMOSOMES, HUMAN, PAIR 16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INVERSION, CHROMOSOME; JAPAN; LEUKEMIA, MYELOID; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 33846702200     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.08.009     Document Type: Article

References (31)

1. Bloomfield C.D., Goldman A., Hassfeld D., and de la Chapelle A. Fourth international workshop on chromosomes in leukemia 1982: clinical significance of chromosomal abnormalities in acute non-lymphoblastic leukemia. Cancer Genet Cytogenet 11 (1984) 332-350
2. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
3. Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., and Rowley J.D. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukaemia. A unique cytogenetic-clinicopathological association. N Engl J Med 309 (1983) 630-636
4. Delaunay J., Vey N., Leblanc T., Fenaux P., Rigal-Huguet F., Witz F., et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood 102 (2003) 462-469
5. Byrd J.C., Ruppert A.S., Mrozek K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461. J Clin Oncol 22 (2004) 1087-1094
6. Schlenk R.F., Benner A., Krauter J., Buchner T., Sauerland C., Ehninger G., et al. Individual patient data-based meta-analysis of patients aged 16-60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol 22 (2004) 3741-3750
7. Tobal K., Johnson P.R., Saunders M.J., Harrison C.J., and Yin J.A.L. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission. Br J Haematol 91 (1995) 104-108
8. Fujieda A., Nishii K., Tamaru T., Otsuki S., Kobayashi K., Monma F., et al. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature. Leukemia Res 30 (2006) 1053-1057
9. Fischer K., Scholl C., Salat J., Frohling S., Schlenk R., Bentz M., et al. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 88 (1996) 3962-3971
10. Stulberg J., Kamel-Reid S., Chun K., Tokunaga J., and Wells R.A. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion. Leukemia Lymphoma 43 (2002) 2021-2026
11. Reilly J.T. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?. Br J Haematol 128 (2005) 18-34
12. Nishii K., Usui E., Katayama N., Lorenzo F.V., Nakase K., Kobayashi T., et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia 17 (2003) 731-737
13. Kadkol S.S., Bruno A., Dodge C., Lindgren V., and Ravandi F. Comprehensive analysis of CBF beta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis. J Mol Diagn 6 (2004) 22-27
14. Monma F., Nishii K., Yamamori S., Hosokai N., Nakazaki T., Lorenzo F.V., et al. Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene. Int J Hematol 80 (2004) 155-158
15. Poirel H., Radford-Weiss I., Rack K., Troussard X., Veil A., Valensi F., et al. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias. Blood 85 (1995) 1313-1322
16. Ritter M., Thiede C., Schakel U., Schmidt M., Alpen B., Pascheberg U., et al. Underestimation of inversion(16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation. Br J Haematol 98 (1997) 969-972
17. Langabeer S.E., Walker H., Gale R.E., Wheatley K., Burnett A.K., Goldstone A.H., et al. Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the UK MRC AML trials. The MRC Adult Leukaemia Working Party. Br J Haematol 96 (1997) 736-739
18. Rowe D., Cotterill S.J., Ross F.M., Bunyan D.J., Vickers S.J., Bryon J., et al. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. Br J Haematol 111 (2000) 1051-1056
19. Larson R.A., Williams S.F., Le Beau M.M., Bitter M.A., Vardiman J.W., and Rowley J.D. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 68 (1986) 1242-1249
20. Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100 (2002) 4325-4336
21. Kobayashi T., Miyawaki S., Tanimoto M., Kuriyama K., Murakami H., Yoshida M., et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukaemia. The Japan Leukemia Study Group. J Clin Oncol 14 (1996) 204-213
22. Kuriyama K., Tomonaga M., Kobayashi T., Takeuchi J., Ohshima T., Furusawa S., et al. Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review. Int J Hematol 73 (2001) 93-99
23. Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261 (1993) 1041-1044
24. Liu P.P., Hajra A., Wijmenga C., and Collins F.S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85 (1995) 2289-2302
25. van der Reijden B.A., Lombardo M., Dauwerse H.G., Giles R.H., Muhlematter D., Bellomo M.J., et al. RT-PCR diagnosis of patients with acute non-lymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 86 (1995) 277-282
26. Dissing M., Le Beau M.M., and Pedersen-Bjergaard J. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?. J Clin Oncol 16 (1998) 1890-1896
27. Van der Reijden B.A., de Wit L., van der Poel S., Luiten E.B., Lafage-Pochitaloff M., Dastugue N., et al. Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis. Hematol J 2 (2001) 206-209
28. Grardel N., Roumier C., Soenen V., Lai J.L., Plantier I., Gheveart C., et al. Acute myeloblastic leukemia (AML) with inv(16)(p13;q22) and the rare I type CBF beta-MYH11 transcript: report of two new cases. Leukemia 16 (2002) 150-151
29. Yamamoto K., Nishikawa S., Minagawa K., Yakushijin K., Okamura A., and Matsui T. Therapy-related myelodysplastic syndrome with inv(16)(p13q22) and I type CBF beta/MYH11 after autologous transplantation: Undetectable fusion transcript in pretransplant progenitor cells. Leukemia Res 30 (2006) 354-361
30. Monma F., Nishii K., Lorenzo F.V., Usui E., Ueda Y., Watanabe Y., et al. Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia. Eur J Haematol 76 (2006) 18-22
31. Kogan S.C., Lagasse E., Atwater S., Bae S.C., Weissman I., Ito Y., et al. The PEBP2betaMYH11 fusion created by inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc Natl Acad Sci USA 95 (1998) 11863-11868